J Biomed Nanotechnol. 2014 Sep;10(9):2149-72. doi: 10.1166/jbn.2014.1958.
Nanocarriers have shown tremendous potential for the target-specific delivery of proteins, genes and drugs. Nanoparticles are fabricated using different natural and synthetic polymers. Natural polysaccharides are often used as building block for developing nano-sized drug delivery vehicles. The physicochemical properties of these materials, such as excellent biocompatibility, low cytotoxicity, surface charges that interact with DNA, protein and RNA, and cost effectiveness, make them exceptional base materials for nanocarrier fabrication. The mechanism for the complex formation of polysaccharides-DNA includes the electrostatic interactions between cationic polymers and anionic DNA to form polyplexes that offer unique possibilities for overcoming cellular barriers by escaping endosomal trafficking followed by cellular internalization and, consequently, enhancing the efficacy of drug and macromolecule delivery to targeted cells and tissue. Depending upon the cellular uptake and trafficking, nanocarriers are designed for different pharmacological and therapeutic applications. However, specific targeting that improves delivery remains an unsolved challenged. The process by which nanocarriers enter cells has important consequences not only for fate of these particles but also for biological systems and therapeutic applications.
纳米载体在蛋白质、基因和药物的靶向递送方面显示出巨大的潜力。纳米颗粒是使用不同的天然和合成聚合物制造的。天然多糖通常被用作开发纳米级药物递送载体的构建块。这些材料具有出色的生物相容性、低细胞毒性、与 DNA、蛋白质和 RNA 相互作用的表面电荷以及成本效益等物理化学性质,使它们成为纳米载体制造的特殊基础材料。多糖-DNA 复合物形成的机制包括阳离子聚合物与阴离子 DNA 之间的静电相互作用,形成聚集体,为克服细胞内体运输提供了独特的可能性,随后是细胞内化,从而增强药物和大分子递送到靶向细胞和组织的效果。根据细胞摄取和运输情况,纳米载体被设计用于不同的药理学和治疗应用。然而,提高递送效率的特定靶向仍然是一个未解决的挑战。纳米载体进入细胞的过程不仅对这些颗粒的命运,而且对生物系统和治疗应用都有重要影响。